| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.087 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |